Almac Discovery

Almac Disc logo

Almac Discovery is a research driven drug discovery company dedicated to the development of novel and innovative approaches to the treatment of diseases of unmet need (including oncology and CNS), by applying a target class approach. The Almac Discovery business model is to develop preclinical stage assets which are then licenced to pharmaceutical or biotech partners for further development. We also look to collaborate with partners to apply our medicinal chemistry and translational biology expertise to targets of mutual interest. Key research themes include deubiquitinase enzymes and protein drug conjugates.

Contact Almac Discovery via their website

News archive

18/05/2021   Almac Discovery Publishes Ground-breaking Cancer Research...more

18/01/2021   Prof Daniel Longley Joins Almac Discovery to Accelerate Colorectal Cancer Research...more

2020   Almac Discovery joins Almac Group in the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code